Download this file

# pmid doi year title Hugo_Symbol
1 35053438 10.3390/cancers14020274 2022 The Antitumor Effect of Caffeic Acid Phenethyl Ester by Downregulating Mucosa-Associated Lymphoid Tissue 1 via AR/p53/NF-κB Signaling in Prostate Carcinoma Cells. BTG2
2 35300216 10.2147/JIR.S341355 2022 The Mutation of <i>BTG2</i> Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma. BTG2
3 35401516 10.3389/fimmu.2022.842439 2022 Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma. BTG2
4 35646048 10.3389/fgene.2022.878618 2022 Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System. BTG2
5 35880434 NA 2022 Emerging role of anti-proliferative protein BTG1 and BTG2. BTG2
6 35928872 10.3389/fonc.2022.932674 2022 Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma. BTG2
7 33021411 10.1080/10428194.2020.1827243 2021 Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4-Not deadenylase in non-Hodgkin lymphoma. BTG2
8 33206936 10.1182/blood.2020005650 2021 Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. BTG2
9 33777778 10.3389/fonc.2021.628807 2021 Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. BTG2
10 33945543 10.1371/journal.pone.0248886 2021 Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes. BTG2
11 34944954 10.3390/cancers13246334 2021 Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System. BTG2
12 32059783 10.1016/j.cell.2020.01.029 2020 Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody. BTG2
13 32457623 10.3389/fphar.2020.00630 2020 Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling. BTG2
14 32565964 10.3892/ol.2020.11552 2020 Comprehensive characterization of driver genes in diffuse large B cell lymphoma. BTG2
15 30350856 10.1002/jcp.27407 2019 Tumor suppressors BTG1 and BTG2: Beyond growth control. BTG2
16 30733272 10.3324/haematol.2018.207928 2019 Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. BTG2
17 31220210 10.1093/carcin/bgz068 2019 Genomic pattern of intratumor heterogeneity predicts the risk of progression in early stage diffuse large B-cell lymphoma. BTG2
18 30184526 10.1159/000492850 2018 MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma. BTG2
19 26757737 10.1007/s00401-016-1536-2 2016 Genomic characterization of primary central nervous system lymphoma. BTG2
20 22323293 10.1091/mbc.E11-06-0524 2012 Intermediate progenitors are increased by lengthening of the cell cycle through calcium signaling and p53 expression in human neural progenitors. BTG2
21 22808135 10.1371/journal.pone.0040332 2012 Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma. BTG2
22 17466295 10.1016/j.yexcr.2007.03.021 2007 Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement. BTG2
23 7768965 10.1007/BF01209594 1995 Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines. BTG2